PO
Poolbeg Pharma PLC
POLBF · OTC
$0.10 +0.00% (+$0.00)
Market Cap £54.0M
P/E Ratio -
Div. Yield -
ROE 53.90%
Piotroski F-Score Weak
1/9Valuation
22 /100
Expensive P/B 6.28x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 22.29%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 73.60%
ROE 53.90%
Asset turnover 0.00x
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 6.17x
Int. coverage N/A
Stability
27 /100
Unstable Beta 1.81x
EPS volatility 37.15%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o POLBF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jeremy Skillington
Employees
15
Headquarters
London